A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor
Open Access
- 8 February 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 65 (4) , 538-546
- https://doi.org/10.1002/(sici)1097-0215(19960208)65:4<538::aid-ijc24>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Single-Chain Antibody-Mediated Intracellular Retention of ErbB-2 Impairs Neu Differentiation Factor and Epidermal Growth Factor SignalingMolecular and Cellular Biology, 1995
- ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.Molecular and Cellular Biology, 1994
- Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growthBritish Journal of Cancer, 1993
- Heregulin induces tyrosine phosphorylation of HER4/p180erbB4Nature, 1993
- Neu and its ligands: From an oncogene to neural factorsBioEssays, 1993
- Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor .alpha. at different locations in Pseudomonas exotoxinBioconjugate Chemistry, 1992
- Prevalence of aberrant expression of the epidermal growth factor receptor in human cancersBritish Medical Bulletin, 1991
- Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblastsCell, 1989
- Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin.Proceedings of the National Academy of Sciences, 1987
- Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.Proceedings of the National Academy of Sciences, 1983